Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
The current price of Abbott Laboratories in the market is โฉ182,674.07, with a 24-hour trading volume of โฉ1.64M. The asset's market cap is โฉ317.64T, after moving -0.16% in the last day.
Tokenized Abbott Laboratories is trading at โฉ183,506.34, with a tokenized market cap of โฉ3.19B and a 24-hour trading volume of โฉ13.02B. The tokenized asset has moved 2.08% in the past 24 hours.